Otitis Media Practice During the COVID-19 Pandemic

Abstract

The global coronavirus disease-2019 (COVID-19) pandemic has changed the prevalence and management of many pediatric infectious diseases, including acute otitis media (AOM). Coronaviruses are a group of RNA viruses that cause respiratory tract infections in humans. Before the COVID-19 pandemic, coronavirus serotypes OC43, 229E, HKU1, and NL63 were infrequently detected in middle ear fluid (MEF) specimens and nasopharyngeal aspirates in children with AOM during the 1990s and 2000s and were associated with a mild course of the disease. At times when CoV was detected in OM cases, the overall viral load was relatively low. The new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen responsible for the eruption of the COVID-19 global pandemic. Following the pandemic declaration in many countries and by the World Health Organization in March 2020, preventive proactive measures were imposed to limit COVID-19. These included social distancing; lockdowns; closure of workplaces; kindergartens and schools; increased hygiene; use of antiseptics and alcohol-based gels; frequent temperature measurements and wearing masks. These measures were not the only ones taken, as hospitals and clinics tried to minimize treating non-urgent medical referrals such as OM, and elective surgical procedures were canceled, such as ventilating tube insertion (VTI). These changes and regulations altered the way OM is practiced during the COVID-19 pandemic. Advents in technology allowed a vast use of telemedicine technologies for OM, however, the accuracy of AOM diagnosis in those encounters was in doubt, and antibiotic prescription rates were still reported to be high. There was an overall decrease in AOM episodes and admissions rates and with high spontaneous resolution rates of MEF in children, and a reduction in VTI surgeries. Despite an initial fear regarding viral shedding during myringotomy, the procedure was shown to be safe. Special draping techniques for otologic surgery were suggested. Other aspects of OM practice included the presentation of adult patients with AOM who tested positive for SARS-2-CoV and its detection in MEF samples in living patients and in the mucosa of the middle ear and mastoid in post-mortem specimens.

Coronavirus Family

The coronavirus (CoV) family is a group of enveloped, positive-sense, single-stranded, highly diverse RNA viruses, with sizes ranging from 60-140 nm in diameter, having crown shape projections on their surface, hence their name: coronaviruses. Four main serogroups exist HKU1, NL63, 229E, and OC43, which have previously been shown to affect humans, and usually caused mild upper respiratory tract infections (URTIs) (Zumla et al., 2016). CoV was also detected from nasopharyngeal aspirates (NPAs) in infants during asymptomatic health visits (Chonmaitree et al., 2015). Research interest in the CoV family has been minimal over the past few decades because RNA viruses were hard to study, and large sero-epidemiolgical surveys conducted during the 1970s and 1980s showed high antibody titers in both children and adults, assuming that CoV infections were common and self-limiting, like any other respiratory viruses (Wenzel et al., 1974; Sarateanu and Ehrengut, 1980; Schmidt et al., 1986).

Over the last two decades, 3 new CoV members emerged: 1) Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV), identified in 2002 in China, which caused a limited-scale epidemic involving 2 dozen countries with ~8000 cases and ~800 deaths (fatality rate: 9.6%) (Drosten et al., 2003); 2) Middle East Respiratory Syndrome-associated coronavirus (MERS-CoV), identified in 2012 in Saudi Arabia, which affected ~2,500 patients and caused ~800 deaths (fatality rate: 35%) (Rasmussen et al., 2016), and 3) SARS-CoV-2, identified in China in 2019, which caused a global pandemic, commonly known as coronavirus disease-2019 (COVID-19), currently affecting >191 millions of patients and causing >4.1 million deaths worldwide (source: Johns Hopkins University Center for Systems Science and Engineering, https://github.com/CSSEGISandData/COVID-19, accessed July 20, 2021).

Evidence for CoV Detection in Otitis Media Cases

Old CoV Serotypes

Table 1 shows published reports on CoV detection in pediatric AOM cases. Using traditional polymerase chain reaction (PCR) and microplate hybridization assays, CoV detection rate in middle ear fluid (MEF) and NPAs in AOM cases was anecdotal. However, when newer real-time PCR assays became available and in widespread use, CoV detection rates increased up to 50% (Chonmaitree et al., 2008). A recent review showed that CoV load in the middle ear in various OM cases was overall very low (Liaw et al., 2021). There were no reports on AOM cases during the SARS-CoV and MERS outbreaks.

Table 1.

CoV detection in AOM cases.

Country	Year	Age	No. of Children	Main Findings
Finland (Pitkaranta et al., 1998)	1998	3m-7y	69	CoV RNA was detected in both MEF and NPA in 5 (5%), in MEF alone in 2 (2%), and in NPA alone in 9 (10%). RSV and HCV were detected in 1 NPA sample.
Finland (Nokso-Koivisto et al., 2000)	2000	2-24m	329	In confirmed AOM cases: 13 NPA CoV+, but no CoV+ MEF specimens.
France (Vabret et al., 2005)	2005	<20y	300	Of the 28/300 patients that had NPA CoV+, 28% had AOM.
Turkey (Bulut et al., 2007)	2006	6-144m	120	5/42 pure viral cases had MEF CoV+.
Finland (Ruohola et al., 2006)	2006	7-71m	79	MEF collected from children with otorrhea from TTs: 1 Moraxella catarrhalis + rhinovirus + CoV and 1 Streptococcus pneumoniae + Haemophilus influenzae + CoV.
USA (Chonmaitree et al., 2008)	2008	6m-3y	294	50% CoV+ detection rate in 440 AOM episodes.
Australia (Wiertsema et al., 2011)	2011	6-36m	180	14.4% NPA and 4.9% MEF samples were CoV+.
The Netherlands (Stol et al., 2012)	2012	<5y	116	MEF collected from children during TT surgery: 4/116 (3%) were CoV+.

AOM, acute otitis media; MEF, middle ear fluid; NPA, nasopharyngeal aspirate; CoV, coronavirus; RSV, respiratory syncytial virus, TT, tympanostomy tube.

SARS-2-CoV

The basis for the hypothesis that suggested SARS-2-CoV infection can spread from the nasopharynx to the middle ear can be explained by the abundant expression of angiotensin converting enzyme (ACE)-2 receptors by goblet cells lining the Eustachian tube mucosa, which are critical for the intracellular entry of SARS-CoV-2 (Matusiak and Schurch, 2020; McMillan et al., 2021).

Albeit the abundance of ACE-2 receptors in the Eustachian tube, only several reports were published linking SARS-2-CoV infection to AOM. The first description was a 35-year-old Turkish female who presented with otalgia and tinnitus. Otoscopy, audiometry, and tympanometry confirmed AOM. Her NPA was positive for SARS-CoV-2, but she had no typical respiratory symptoms (Fidan, 2020). Because myringotomy was not performed, it was impossible to determine SARS-CoV-2 presence in the MEF. A case-series publication described 8 Iranian adult COVID-19 patients with AOM (Raad et al., 2021). Interestingly, 1 patient tested negative for SARS-CoV-2 from the oropharynx, but his MEF sample, obtained via myringotomy, tested positive. A 23-year-old American COVID-19 patient presented with complicated AOM and facial palsy, although his MEF sample tested negative for SARS-CoV-2 (Mohan et al., 2021). SARS-CoV-2 was detected in the mastoid and middle ear mucosa in autopsies performed 14-46h post-mortem in 2/3 COVID-19 deceased adult patients who did not have a preceding AOM episode (Frazier et al., 2020).

Reduction in Otitis Media Burden

Following the declaration of the COVID-19 pandemic by the World Health Organization in early March 2020 (Jee, 2020), preventive proactive measures were imposed to limit SARS-CoV-2 transmission and infection, including social distancing, recommendations to stay at home, lockdowns in varying severities, closure of workplaces, kindergartens, and schools, increased hygiene measures, increased use of antiseptics and alcohol-based gels, frequent temperature measurements, and mask-wearing.

Reduction in Overall Pediatric Emergency Department Visits

The COVID-19 pandemic and national and international interventions aimed at limiting its spread deeply changed “traditional” healthcare habits, limiting people’s mobility and access to medical facilities. Some Health and Welfare policy measures even discouraged non-urgent access to (pediatric) emergency departments (PED), and more generally any frontal visits to family physicians/pediatricians, which were not considered urgent. A substantial reduction in the number of pediatric referrals/admissions to PEDs has been globally reported in Singapore, USA, Italy, and Argentina (Chong et al., 2020; McBride et al., 2020; Ferrero et al., 2021; Finkelstein et al., 2021; Pepper et al., 2021).

Reduction in Pediatric AOM/OME Cases

The measures adopted to contain the COVID-19 pandemic also resulted in a decrease of airborne-mediated respiratory infections other than COVID-19, including URTI, bronchiolitis, and AOM (Kuitunen et al., 2020; Lin et al., 2020; Torretta et al., 2020; Alde et al., 2021; Angoulvant et al., 2021; Torretta et al., 2021). In addition, the number of children presenting to healthcare facilities for non-urgent complaints, such as AOM or otitis media with effusion (OME), was also affected by the fear of contracting COVID-19 at the hospital or the outpatient clinics. Thus, there was a decrease in healthcare utilization for pediatric AOM/OME.

Reports from Milan, the largest and the most densely populated city in Lombardia, the Northern Italian region placed at the epicenter of the Italian epidemic, where all elective medical activities were discontinued between March-May 2020, showed a substantial reduction in pediatric OM burden (Alde et al., 2021; Torretta et al., 2021). All outpatient periodic visits for otitis-prone children regularly followed at a tertiary outpatient clinic were replaced with telephone call contacts during the lockdown, and parents were asked to give a subjective assessment about the child’s condition and describe ear-related complaints (ongoing AOM episodes, with/without tympanic membrane perforation, antibiotic treatments). The results of this survey were compared with the corresponding assessments reported 1 year prior. A statistically significant reduction in the mean number of AOM episodes and systemic antibiotic treatments during the COVID-19 first lockdown period compared with the previous year was reported, and 82% of parents had an impression of clinical improvement during the lockdown (Torretta et al., 2021).

Furthermore, a positive effect was reported on OME prevalence among Milanese children who attended an outpatient clinic during two pre-lockdown periods (May-June 2019 and January-February 2020) vs. the first post-lockdown period (May-June 2020) (Alde et al., 2021). It was found that OME prevalence dramatically decreased after the lockdown: 41%, 52%, and 2%, during the 1^st, 2^nd and 3^rd periods, respectively. The resolution rate of OME was significantly higher in May-June 2020 when compared with the corresponding period of May-June 2019 (93% vs. 21%).

These findings were in line with results from a study conducted in De Marchi, Milan’s largest PED, aiming to measure the children’s flow, in terms of diagnosis related to any ear, nose, and throat (ENT) diseases during the lockdown (February-May 2020), compared with the corresponding previous period (February-May 2019) (Torretta et al., 2021). They found a substantial regional decrease in children’s attendance to that PED; this effect was particularly noticeable when the analysis was restricted to ENT diagnoses (80.4% vs. 19.5%, February-May 2019 and February-May 2020, respectively; p-value < 0.001), including middle ear infections (92.8% vs. 7.2%). In addition, non-complicated AOM episodes more frequently occurred in February-May 2019 (92.0% vs. 8.0%), but no significant differences were found between the number of patients with complicated middle ear diseases (95.8% vs. 4.2%).

Table 2 summarizes current worldwide data on AOM burden reduction. A reduction in AOM burden was observed in many countries. In France, Angoulvant et al. (2021) conducted a time-series analysis for PED visits and related hospital admissions in the greater Paris area, from January 2017 to mid-April 2020. A global reduction in post-lockdown PED visits and hospital admissions was found (-68% and -45%, respectively), with a significant decrease (>70%) in the observed over expected rates of several infectious diseases, including AOM. These results are in line with the findings by Kuitunen et al. (2020), who evaluated the immediate effect of Finnish national lockdown on PED visits. A major decrease in the daily rate of PED visits was reported, along with an overall decrease in the number of hospitalized patients for any respiratory disease during the lockdown, compared with the previous period. A study from 27 PED across the USA has demonstrated that visit numbers decreased by 45.7% (range: 36.1%-96.9%) during the COVID-19 pandemic in 2020 when compared with the same period during 2017-2019. The largest decrease was for respiratory disorder visits (DeLaroche et al., 2021). A sharp decline was observed for both AOM and URTI: 75.1% and 69.9%, respectively.

Table 2.

Reduction in otitis media burden during COVID-19 pandemic.

Country	Setting	COVID-19 Period	Comparative Period(s)	Variable	Rate Difference
Finland (Kuitunen, 2021)	Two hospitals	16/3/2020-12/4/2020	17/2/2020-15/3/2020	No. of AOM visits	-1%, -30%
USA (DeLaroche et al., 2021)	27 pediatric hospitals	15/3/2020-31/8/2020	15/3/2017-31/8/2017; 15/4/2018-31/8/2018;	Diseases of the ear and mastoid process	-68%
			15/4/2019-31/8/2019
France (Angoulvant et al., 2021)	6 Paris area hospitals	18/3/2020-19/4/2020	1/1/2017-17/3/2020	No. AOM referrals	-70%
			(Time interrupted)
Spain (Enrique et al., 2021)	Tertiary pediatric hospital	1/1/2020-30/6/2020	1/1/2010-31/12/2019	No. of mastoiditis cases	+45%
			(Time interrupted)
Italy (Iannella et al., 2021)	Telephone/telemedicine contact with families of children with OM	1/2/2020-30/4/2020	1/2/2019-30/4/2019	No of AOM episodes,	-81%
				No. of otorrhea episodes,	-97%
				No. of ABx/month	-89%
USA (DeLaroche et al., 2021)	Tertiary and community health providers	1/1/2020-13/3/2020;	1/1/2019-13/3/2019;	No. of tympanostomy tube procedures	-64%
		1/6/2020-13/12/2020	1/6/2019-13/12/2019
		(post-lockdown)
Italy (Alde et al., 2021)	Tertiary pediatric hospital	1/5/2020-30/6/2020	1/5/2019-30/6/2019;	No. of children with OME,	-40%
		(post-lockdown)	1/1/2020-29/2/2020;	No. of children with type B tympanometry	-95%
The Netherlands (van de Pol et al., 2021)	Tertiary hospital and clinics network	1/3/2020-31/5/2020	1/3/2019-31/5/2019	No. of AOM episodes	-10%
USA (Ramgopal et al., 2021)	37 Children’s hospitals	1/1/20-31/12/20	1/1 to 31/12 for each year: 2010-2019	No. of AOM visits	-55%
Italy (Torretta et al., 2021)	Pediatric emergency Department	21/2/2020-4/5/2020	1/2/2019-21/2/2020	No. of AOM visits	-92%
Germany (Rohe et al., 2021)	146 ENT practice centers	Q2-Q3 2020	Q2-Q3 2019	No. of AOM visits	-43%
UK (Stansfield et al., 2021)	One large center	17/3/2020-17/6/2020	17/3/2019-17/3/2019	No. of emergency department OM visits	-86%
Italy (Torretta et al., 2020)	Telephone/telemedicine contact with families of children with OM	9/3/2020-19/5/2020	1/2/2020-30/4/2020	No. of AOM episodes	-90%
UK (Quraishi et al., 2021)	3 secondary care ENT departments	1/3/2020-28/2/2021	1/3/2019-29/2/2020	No. of AOM visits	-26.9%
				No. of acute mastoiditis cases	-14.3%
The Netherlands (Hullegie et al., 2021)	Julius General Practitioners’ Network	1/3/2020-28/2/2021	1/3/2019-29/2/2020	AOM, 0-2 years	-47.6%
				AOM, 2-6 years	-33.7%
				AOM, 6-12 years	-6.8%
Switzerland (Bucher et al., 2021)	Tertiary referral center	16/3/2020-26/4/2020	16/3/2019-26/4/2019	AOM, all ages	-79.5%

AOM, acute otitis media; MEF, middle ear fluid, ABx, antibiotics; OM, otitis media.

However, not all studies reported a downward trend in OM burden. A Spanish study showed that although there was no increase in the total ENT infections during January-April 2020 when compared with the same period in 2010-2019, there was a significant increase in complicated cases of mastoiditis (e.g., subperiosteal abscess, facial nerve paralysis, intracranial abscess). Although 54% of these patients were exposed to COVID-19 patients, only 15.4% had IgG antibodies (Enrique et al., 2021). The authors explained the increased complication rates might be explained due to lack of staff during the initial pandemic, and that public fear of getting infected may have prevented patients and parents from seeking medical treatment earlier.

Based on these reports, we speculate that vigorous lockdown measures also had a critical impact on the spread of many infectious diseases other than COVID-19 in children. Data are still accumulating.

Reduction in Antibiotics Prescription Rates for AOM

Data regarding antibiotics prescription rates for AOM during the COVID-19 pandemic are limited. The COVID-19 era provided a unique opportunity for healthcare providers to utilize treatment guidelines for common childhood infections, such as AOM. The “Choosing Wisely” campaigns, presented in >20 countries, provide statements regarding when to use antibiotics, to avoid unnecessary treatment of viral infections (Leis et al., 2020). New toolkits, such as the “Cold Standard toolkit”, published by the Canadian College of Family Physicians, as part of the “Choosing Wisely” campaign, provide information on how to use antibiotics in virtual care visits during the COVID-19 era (https://choosingwiselycanada.org/perspective/the-cold-standard/). This campaign encourages a conversation between clinicians and patients to avoid antibiotic overuse.

In general, a delayed prescription is accepted for AOM cases; the prescription is filled and purchased only if symptoms persist (Spurling et al., 2017). As described by Leis et al. (2020), infants >6 months with otalgia should be seen in person only when symptoms persist >48h, fever >39°C despite antipyretic medications, or in ill-looking children. Otherwise, a virtual visit can take place, and the child can be treated with oral pain analgesics, according to the Canadian Pediatric Society guidelines on AOM management (Le Saux et al., 2016). However, virtual visits are limited in their diagnostic accuracy, and therefore may eventually lead to over-prescription of antibiotics (Leis et al., 2020).

A Scottish study examined the pandemic’s impact on outpatient antibiotics prescriptions rates, in comparison with the preceding year. It was shown that initially, there was a sharp increase in the numbers of prescriptions used for respiratory infections, followed by a decrease for all age groups, which was more pronounced in children aged 0-4 years. They suggested that the initial peak was due to “just-in-case” prescriptions. The decrease may be due to fewer URTI episodes and increased self-care practice and a reduced number of patients with bacterial infections presenting to their general practitioners (GPs) (Malcolm et al., 2020).

A Dutch study compared the number of GPs’ consultations and antibiotic prescription rates during March-May 2019, with the same period in 2020. The number of respiratory/ear infections decreased during the pandemic period from 16,672 to 15,580 and the antibiotics prescription rate decreased from 21% to 13%, respectively, without an increase in acute mastoiditis cases (van de Pol et al., 2021).

A web-based survey among 169 Israeli pediatricians circulated during the pandemic aimed to evaluate the frequency of telemedicine use, as well as its influence on decision-making in clinical scenarios, such as AOM. They reported an increase in daily use of text messages, pictures, and videoconference from 24%, 15%, and 1% before the pandemic to 40%, 40%, and 12% during the lockdown, respectively. Interestingly, there was a high likelihood of prescribing antibiotics for suspected AOM via telemedicine contacts (Grossman et al., 2020).

Otologic Surgery

Changes in Concept

COVID-19 emergence required otologists to adopt a changed mindset for otologic office procedures and ear surgery. Otologic surgery, including drilling of the mastoid, is known to cause a substantial dispersion of small and large aerosols (Anschuetz et al., 2021; Chari et al., 2021; Hajiyev and Vilela, 2021; Merven and Loock, 2021; Sharma et al., 2021) and droplets (Sharma et al., 2020; Mohan et al., 2021; Sharma et al., 2021), and is a cause of concern regarding contamination in the operating room (OR). To prevent unnecessary risk of infection, otologic procedures were categorized as urgent versus elective, according to different authors and otolaryngological societies (Kozin et al., 2020; Leboulanger et al., 2020; Pattisapu et al., 2020; Saadi et al., 2020), suggesting that urgent operations should be performed, while all other operations should be postponed, depending on the pathology and the patient’s preference.

To overcome the obstacle of personal contamination through patient care, several methods have been studied/suggested (Cottrell et al., 2020; Ally et al., 2021; Chari et al., 2021): personal protective equipment (PPE) for clinics and the ORs, a shift to telehealth communication, environmental protection (microscope draping, tents), modification of surgical settings and alteration of surgical techniques (actively preferring endoscopic approaches, use of exoscopes, use of enhanced smoke/suction devices, povidone-iodine irrigation of mastoid). SARS-CoV-2 testing is pre-operatively advised, and if the test is negative, additional precautions may not be necessary. When SARS-CoV-2 testing is not possible, or when testing positive, extra care should be taken as listed below.

Personal Protective Equipment

PPE can be divided into two categories: 1) respiratory protection (N95 respirator, powered air-purifying respirator [PAPR]), and 2) body protection, including eye protection, sterile and waterproof clothes around the neck, and disposable cap, gown, overshoes, and gloves. PPE is advised for any surgery performed, and especially for procedures with a high aerosol dispersion potential, such as mastoidectomy (Ayache and Schmerber, 2020; Gordon et al., 2020; Kozin et al., 2020; Leboulanger et al., 2020; Sharma et al., 2021).

Surgical Setting

It was advised that the minimal number of staff enter the OR, and only the most skilled surgeon operating (Kozin et al., 2020). It is advised that for adults, VTI should be performed under local anesthesia. For pediatric cases, bag ventilation is not advised, and all procedures should be performed with endotracheal intubation. Operating rooms with negative pressure ventilation should be used as with a designed filtration system (Leboulanger et al., 2020).

Surgical Technique

Regarding surgical techniques, the endoscopic approach is preferred, if possible (Ayache et al., 2021). When a mastoidectomy is unavoidable, it should be performed without drilling, if possible, and by using instruments such as a hammer, gouge, and/or curette, together with a continuous high-powered suction that should be placed next to the surgical field. The use of monopolar cautery and laser may result in an increased risk of viral dissemination, and thus should be avoided (Ayache and Schmerber, 2020; Kozin et al., 2020; Lavinsky et al., 2020; Leboulanger et al., 2020; Saadi et al., 2020). Exoscopes should be chosen in place of microscopes, as exoscopes place the surgeon and staff a more secure distance from the surgical field (Gordon et al., 2020; Kozin et al., 2020; Ally et al., 2021; Ridge et al., 2021; Tu et al., 2021).

Environmental Protection

Various methods of surgical field isolation for better staff protection have been proposed (Cottrell et al., 2020; Panda et al., 2020; Chari et al., 2021; Hajiyev and Vilela, 2021). Table 3 describes the proposed materials. All these methods aim to isolate the surgical field to prevent aerosol and particle dispersion. Environmental protection uses commonly available surgical drapes and other equipment traditionally present in the OR. It is important to note that most of the proposed methods are prototypes (McCarty et al., 2021), and have not yet been rigorously proven.

Table 3.

Draping techniques during otologic surgery.

Author	Drape “tent” (Other than Otological Surgical Drape/4K 3D Exoscope Drape)	Accessories	A place for Surgical Assistant and Instrument Table	Ease of Construction (Yes/No)	Cost	Name of Installation
Panda et al. (2020)	Steri-Drape (3M)	Gottingen laser support table	+	Y	+
Cottrell et al. (2020)	C-arm draping	–	–	N	++
(Hajiyev and Vilela, 2021)	Modified chair drape	–	–	Y	+
Chari et al. (2021)	Steri-Drape (3M)	–	–	Y	+	Ototent 1
Chari et al. (2021)	Modified Zeiss OPMI microscope drape (Carl Zeiss, Meditec AG, Germany)	–	–	Y	++	Ototent 2
Tolisano et al. (2020)	Modified Zeiss OPMI microscope drape (Carl Zeiss, Meditec AG, Germany)	PVC pipes as a specialized frame,	–	N	++	Covid-19 Airway Management Isolation Chamber with otologic modification (CAMIC-Ear)
		Sterile bags
Ally et al. (2021)	A plastic sterile drape (3M Steri-Drape 1015)	–	–	Y	+
Lawrence et al. (2020)	CE-marked sterile polyethylene drape with a custom-made hole over the lens cap	‘L’ support	–	Y	+

+, not expensive; ++, expensive.

Changes in Ventilating Tube Surgery

Mohan et al. examined the risk of aerosol-generating procedures, such as suctioning of MEF during ventilating tube insertion (VTI), by performing a cadaveric simulation of bedside myringotomy and fluorescein-labeled fluid injection into the middle ear to examine the potential risk (Mohan et al., 2021). Image analysis showed no fluid in the proximal external auditory canal nor the ear speculum following the procedure and suctioning. Unlike first speculations, there was no measured increase in aerosol particle numbers during VTI (Campiti et al., 2021).

Another report from Milan addressed the clinical activities pertinent to pediatric OM and modifications of surgical waiting lists during the COVID-19 pandemic, with patient selection based upon the priority of certain conditions, as defined by the Italian Society of Otorhinolaryngology-Head and Neck Surgery (Torretta et al., 2020). Priority for VTI surgery was granted to candidates with persistent OME, causing a negative impact on language development. During the pandemic, VTI rates significantly decreased among Bostonian children: the age of patients undergoing surgery increased, and more children were sent for surgery in a tertiary setting (Diercks and Cohen, 2021). It was also reported that in young Floridian children, the prevalence of intraoperative OME during the COVID-19 pandemic was significantly lower compared with pre-COVID-19 as assessed during VTI surgery (65% vs. 83%, p <0.001) (Nguyen et al., 2021).

Telemedicine

Telemedicine is the branch of telehealth that connects patients-to-providers and providers-to-providers, for the delivery of healthcare at a distance. Although this development offered greater healthcare access, telemedicine is limited in accuracy and general acceptance by a lack of physical examination and real-time intervention, remaining as a service for special circumstances, or as an adjunct to in-office and in-hospital visits. Telemedicine has been well-received as a modality for patient visits. Caregivers and care providers alike report high satisfaction in both the convenience and the care provided by the service (McIntosh et al., 2014).

The COVID-19 pandemic significantly expanded the usage of telemedicine. The call for strict socially distancing, and patients’ fears of any medical environment, meant that any means for assessment was preferable to the risk of contracting the virus. The result has been more widespread use of newly developing technologies, permitting triage and assessment of patients remotely. For OM, evaluation of the tympanic membrane and the middle ear by a tele-provider is conducted in one of two ways: video microscopy or video otoscopy, the latter of which also often permits pneumatic otoscopy. The exam is carried out by the patient’s family or a telemedicine facilitator, and findings may be transmitted to a provider in real-time, or recorded and delivered for interval review (Metcalfe et al., 2021).

Types of Telemedicine

1. Home-based telemedicine (HBT) starts with a smartphone. Instrumentation in the home setting may be owned by the patient or may be sent to the family, in anticipation of a telemedicine visit. A hybrid model for telemedicine care, blending telemedicine with an in-person office visit, can be offered when further needs arise for better information or from the opportunity for a different interaction with the provider.

2. Facility-based telemedicine (FBT) requires that the patient be brought to a clinical setting with visualization technology available for use. Information is sent to a physician or advanced-practice provider located at a distance.

Two temporal modes of telemedicine exist:

1. Synchronous telemedicine involves real-time telephone or audiovisual interaction via smartphone, tablet, or computer with patients and families. This may occur in the patient’s own home in a direct-to-consumer model or an external facility.

2. Asynchronous telemedicine includes “store and forward” technology in which messages, images, and data are securely sent and subsequently reviewed and responded to within a certain time interval. The utilization of patient portals is often utilized.

Telemedicine for AOM

Because AOM is the most common reason for pediatric outpatient visits, HBT can offer earlier, more accurate diagnoses for primary care providers, meaning more judicious antibiotic usage, and better anticipation of impending complications. Telemedicine in AOM is equivalent to office-based visits regarding recommendations for surgery, additional testing, or routine follow-up (Kolb et al., 2021). The challenge of patient assessment in the setting of potential OM is in direct visualization of middle ear structures. Another important factor for this process is the attainment of satisfactory image quality. Regulatory restrictions are an additional limitation at present. Licensure, and credentialing providers, limit the extent of care that can be provided. In some organizations, the provider is a trained medical assistant. Because any healthcare provider can be trained, this approach to a hybrid model of telemedicine and in-person care is termed “Provider Assisted Telemedicine” (PAT). Additionally, tympanometry can be performed when performing FBT for AOM: the delivering provider obtains a tympanogram which is then messaged to the remote, directing provider ( Figures 1 – 3 ).

Figure 1.

Medical assistant telemedicine in use. A physician provider to the far right is watching the medical assistant at the far left on the screen using a device to examine the ear of a patient. The device will relay images of the patient’s ear exam to the physician (Photo used with permission of A. Saporito. Image courtesy of Dr. Patrick Barth).

Figure 3.

Otoscopy via telemedicine. The camera is at top of the monitor.

Figure 2.

Possible telemedicine setup. A two-screen setup allows the medical record to be seen on the left, while the examination can be seen on the right. A white hand-held video-otoscope is seen to the left of the keyboard (Image courtesy of Dr. Udayan Shah).

Interestingly, studies on telemedicine and antibiotic prescription before the COVID-19 era have shown that children seen by telemedicine visits received less diagnostic testing and would not seek antibiotic treatment if they have received a clear explanation on diagnosis, safety, treatment plan, and reassurance (Mangione-Smith et al., 1999).

Telemedicine was found to help guide decision-making regarding medical and surgical management for AOM, though a consensus in the literature on the benefits of telemedicine in pediatrics for triage and assessment of otitis media has not yet been established. Telemedicine continues today to demonstrate its utility during the COVID-19 pandemic.

Conclusion

The paucity of reports of living COVID-19 patients with AOM, particularly for children, can be explained by the variability in clinical severity and viral load (with more severe clinical course portending a higher viral titer), very low incidence of myringotomies to aspirate MEF, low levels of passive reflux from the nasopharynx, a low predilection for SARS-CoV-2 to invade the middle ear mucosa and inadequate detection technique. In addition, hospital admission reports and insurance-claims data showed a substantial decrease in OM visit rates and even related complications during the COVID-19 pandemic periods, compared with previous years. Otologic surgeons identified several methods to minimize the spread of the COVID-19 virus. These methods include PPE, environmental protection, and alteration of surgical methods and techniques. The combination of these methods may best protect the surgeon and the staff against this ever-changing disease.

Future research should focus on OM burden following the introduction of SARS-2-CoV vaccines (currently approved only for children >12 years), relaxation of lockdown measures, and re-emergence of viral URTIs other than SARS-CoV-2, and appearance of new SARS-CoV-2 variants.

Author Contributions

TM, JP, and STa contributed to conception and design of the study. TM and STa identified and assigned areas of review. TM, JP, and STa wrote the first draft of the manuscript. US, STa, STo, PM, AK, and PB wrote sections of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.